Mixed connective tissue disease (MCTD) is classified as an autoimmune disorder that has the potential to impact individuals of all genders and age groups. However, it predominantly affects women under the age of 50. Diagnosing this condition can be challenging due to the extensive overlap of symptoms with other autoimmune diseases. Furthermore, the symptoms experienced by individuals with MCTD can differ significantly. The treatment approach and prognosis for mixed connective tissue disease are contingent upon the specific signs and symptoms exhibited by each patient.
Understanding Overlap Disease
When the immune system mistakenly identifies healthy tissues in the body as threats and launches an attack against them, autoimmune disorders occur. One such condition is known as mixed connective tissue disease (MCTD), which falls under the category of overlap diseases. These conditions are particularly challenging to diagnose accurately due to the similarity in symptoms shared with multiple disorders. MCTD can manifest with signs and symptoms that are commonly associated with lupus, scleroderma, and polymyositis.
Understanding Lupus
Lupus is an autoimmune disease that shares overlapping symptoms with mixed connective tissue disease. It is known to cause the immune system to attack organs and tissues within the body, including the skin, joints, kidneys, heart, and lungs. This results in chronic inflammation, which can lead to various complications. While symptoms may differ from one individual to another, some of the most commonly experienced symptoms include fever, fatigue, joint pain, headaches, and the development of skin lesions.